# SONALASENSE INC: Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | SONALASENSE INC |
| Location | San Carlos, CA |
| Project | Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme |
| Project number | 5R44CA275508-03 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $497,384 |
| Awarded | 2026-09-17 |
| Project period | 2023-04-01 to 2027-08-31 |
| UEI | LC3GHFGF2KK1 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11408427). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.